Vimarsana
Biggest News Aggregation in the World

Page 33 - Genetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetics Inc Today - Breaking & Trending Today

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris® - Vimarsana News

Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®

Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, Aug. 15, 2023 -- Myriad Genetics, Inc., a leader in... -Today at 07:06 am- MarketScreener

JPMorgan Chase & Co. Cuts Myriad Genetics (NASDAQ:MYGN) Price Target to $17.00 - Vimarsana News

JPMorgan Chase & Co. Cuts Myriad Genetics (NASDAQ:MYGN) Price Target to $17.00

Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price target cut by stock analysts at JPMorgan Chase & Co. from $18.00 to $17.00 in a report released on Monday, Benzinga reports. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 1.43% […]

Source: wkrb13.com
United States DTC Wellness Testing Market Report 2023-2028: Rising Consumer Demand for Convenient and Affordable Healthcare Boosting Adoption - Vimarsana News

United States DTC Wellness Testing Market Report 2023-2028: Rising Consumer Demand for Convenient and Affordable Healthcare Boosting Adoption

/PRNewswire/ -- The "United States DTC Wellness Testing Market - By Test Type, Offerings, Distribution Channel, Sample Type, Region, Competition, Opportunity,...

United States Women Health Laboratory Testing Market Analysis 2023-2028 - Cancer Prevalence Among Women Creates New Opportunities - Vimarsana News

United States Women Health Laboratory Testing Market Analysis 2023-2028 - Cancer Prevalence Among Women Creates New Opportunities

/PRNewswire/ -- The "United States Women Health Laboratory Testing Market by Hereditary Cancer, Reproductive Health and Infectious Diseases, Prenatal Screening...

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial ... - Vimarsana News

Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial ...

SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Intermountain Precision Genomics, part of the Intermountain